Tonix TNX-102 SL: Innovating Fibromyalgia Treatment in Development
In this interview, we sit with Seth Lederman, CEO of Tonix Pharmaceuticals, about their new drug in development for...
Breakthroughs in Post-Polio Syndrome Treatment: Grifols’ Innovative Approach
In this discussion, Dr. Jörg Schüttrumpf, Chief Scientific Innovation Officer at Grifols, delves into the promising results of their...
Durect Transforming AH Treatment with Larsucosterol’s Promise
In this interview, Jim Brown, CEO of Durect Corporation, shared insights into the treatment of Alcohol-Associated Hepatitis (AH) with...
Hacking the Placebo Effect: How AI Is Reshaping Clinical Trial Variability
AI is making significant strides in the rapidly evolving field of clinical trials. Dominique Demolle, CEO of Cognivia, shares...
PathAI: Clinical Trial Pathology Revolution
In this interview, we engage with PathAI leaders: Eric Walk, MD, Chief Medical Officer; Ella Stewart, Senior Product Manager;...
Azitra: Revolutionizing Skin Disease Treatment
In this interview, Francisco Salva, CEO of Azitra, shared insights into the company’s innovative approach to treating skin diseases....
Pharma’s Future: Graham Clark on Trends and Challenges
In the dynamic world of pharmaceuticals, staying ahead of trends and challenges is vital. Graham Clark, CEO of Phastar,...
Medable’s France CNIL Regulatory Breakthrough: Pioneering Global Clinical Trials
Medable has achieved a significant milestone by securing regulatory approval from France’s CNIL, enhancing its global clinical trial capabilities....
Revolutionizing Clinical Trials with AI and Decentralization
In the evolving world of clinical trials, AI and decentralization are key drivers of change. Iddo Peleg, CEO of...
Transforming Clinical Trials with AI: Insights from the Frontline
In the rapidly evolving landscape of clinical trials, technology is a game-changer. Dr. Michelle Papka, Ph.D., Founder and President...